U.S. Communications Stock News

NYSE:HESM
NYSE:HESMOil and Gas

Does Hess Midstream’s (HESM) Higher Payout Deepen Its Cash-Return Story or Limit Strategic Flexibility?

Hess Midstream LP recently declared a quarterly cash distribution of US$0.7888 per Class A share for the June 30, 2026 quarter, up US$0.0096 from the prior quarter and payable on August 14, 2026 to shareholders of record as of August 6, 2026. This higher payout highlights management’s continued emphasis on returning cash to investors and may be read as a signal of confidence in the partnership’s underlying cash generation. We’ll now examine how this increased quarterly cash distribution fits...
NYSE:HUBS
NYSE:HUBSSoftware

Is HubSpot (HUBS) Stock Fully Priced After Its AI Push?

HubSpot stock has rebounded sharply in the short term, yet the longer term share price record and a low value score suggest the current valuation may still be demanding for new investors. Over the past 5 years, HubSpot shareholders have seen the share price decline 64.7%, which raises questions about how much of the business opportunity is already reflected in today’s price. The recent launch of Agent Hub and Agent Builder can support confidence in HubSpot’s role in AI powered customer...
NasdaqGM:OLLI
NasdaqGM:OLLIMultiline Retail

Ollie's (OLLI) Stock Looks Reasonable On Cash Flow While Earnings Look Stretched

Ollie's Bargain Outlet Holdings has had a difficult run for shareholders over the past year, yet the valuation picture is mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting the stock trades below that level while market based multiples point the other way. The share price is down 46.8% over the past year, which raises the question of whether the current level already reflects weaker expectations. Future cash flow growth from the discount retail format can support...
NYSE:WRB
NYSE:WRBInsurance

W. R. Berkley (WRB) Posted Stronger Q2 Results, Is The Stock Now Too Expensive?

W. R. Berkley (WRB) has drawn fresh attention after reporting second quarter 2026 revenue of US$3,716.12 million and net income of US$452.26 million, with earnings per share higher than a year earlier. See our latest analysis for W. R. Berkley. At a share price of US$73.38, W. R. Berkley has seen its 30 day share price return of 4.04% and 90 day share price return of 10.55% supported by recent earnings and ongoing buybacks, while a 5 year total shareholder return of 156.02% points to...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

The Bull Case For Huntington Bancshares (HBAN) Could Change Following Mixed Earnings And Credit Trends - Learn Why

Huntington Bancshares’ latest quarterly report showed higher net interest income of US$2,052 million and net income of US$727 million, alongside increased net charge-offs of US$119 million and an unchanged US$0.155 common dividend, with preferred dividends declared across multiple series. These results highlight a contrast between stronger core earnings and rising credit costs, as the bank continues to return capital via dividends and a completed US$50 million share repurchase. We’ll now...
NYSE:NVST
NYSE:NVSTMedical Equipment

Envista Holdings (NVST) Could Be 6% Undervalued On Q2 Earnings Focus

What triggered the latest move in Envista Holdings stock Envista Holdings (NVST) shares moved 5.2% higher after investors focused on the company’s upcoming Q2 2026 results, due on August 5, and on expectations for revenue and earnings performance. See our latest analysis for Envista Holdings. That 5.2% single day move comes on top of a stronger recent trend for Envista Holdings, with a 7 day share price return of 6.15% and a year to date share price return of 28.08%. The 1 year total...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Amgen Stock Leads 3 Cardiovascular Pharma Picks After Novo Nordisk Trial Miss

A failed late stage heart drug trial at Novo Nordisk, with shares in Copenhagen down 8.6% and U.S. ADRs down 9.8% in premarket trading, has pushed cardiovascular pipelines into the spotlight. When a high profile project like ziltivekimab does not deliver a meaningful reduction in major cardiovascular events, attention often shifts to other companies exposed to the same news. This article walks through 3 stocks from our Cardiovascular Pharma Stocks With Upside From Novo Nordisk Setback...
NasdaqCM:RIOT
NasdaqCM:RIOTSoftware

Does Zacks’ Strong Sell on Riot (RIOT) Hint at Deeper Cracks in Its Earnings Story?

Riot Platforms, Inc. recently saw analyst sentiment sour as Zacks assigned it a Rank #5 (Strong Sell) following earnings estimate cuts, ahead of the company’s now-upcoming 5 August 2026 earnings report. This shift contrasts with previously favorable brokerage recommendations and highlights a widening gap between earnings-based signals and traditional analyst ratings for the Bitcoin miner and data center operator. Next, we’ll examine how this recent Strong Sell rating and earnings uncertainty...
NYSE:TOST
NYSE:TOSTDiversified Financial

Toast (TOST) Stock Looks Fair On Fair Value But Rich On Earnings

Toast stock has delivered a 58.9% gain over the past three years, yet on current checks it screens as expensive, with an Excess Returns intrinsic value estimate that sits close to the market price while traditional earnings multiples lean toward an overvaluation signal. Recent shorter term share price weakness and a low overall value score add to the question of whether the current price leaves much room for error. Toast has returned 58.9% over three years, which suggests long term holders...
NasdaqGS:SAIA
NasdaqGS:SAIATransportation

Does Saia (SAIA) Look Expensive Given Its Fair Value Gap?

Saia stock has delivered a 45.2% gain over the past five years, yet both the intrinsic value estimate using a Discounted Cash Flow (DCF) approach and market multiples currently point to the shares trading at a premium. Over the last five years, Saia has returned 45.2%, which means long term holders have already seen a meaningful payoff from the story so far. Strong recent operating execution and record revenue may support expectations for future cash flows, while a sizeable investment plan...
NYSE:SRE
NYSE:SREIntegrated Utilities

Is Sempra (SRE) A Bargain Following Earnings Optimism Ahead Of August 6?

Earnings optimism puts Sempra (SRE) in focus ahead of August 6 report Investor attention is turning to Sempra (SRE) as Wall Street anticipates a year over year earnings increase in the upcoming August 6 quarterly report, with expectations already influencing recent stock activity. See our latest analysis for Sempra. At a recent share price of US$89.58, Sempra has seen its 7 day share price return decline 4.13% and its 90 day share price return fall 5.38%. This contrasts with its 1 year total...
NYSE:CNK
NYSE:CNKEntertainment

Cinemark (CNK) Stock Looks Cheap On Its 140% Five Year Run

Cinemark Holdings has delivered a 140.1% total return over the past five years, yet its valuation signals are pulling in different directions, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) suggesting the stock trades at a discount while earnings based multiples look less forgiving. Over five years, a 140.1% return points to a stock that has already rewarded long term holders and may now draw closer scrutiny on price paid versus future cash flows. Recent record...
NYSE:LMND
NYSE:LMNDInsurance

Lemonade (LMND) Stock Gains Traction As Losses Tighten And Cash Flow Improves

Lemonade came into this earnings print with a bruised stock that had fallen about 25% over the past month, yet shares ticked higher by roughly 3% on the day. That move reflects one thing above all: investors saw a company still posting losses but tightening the screws on profitability. The headline from Q2 is the squeeze on those losses. Net income excluding extra items was a loss of US$43.4m and basic earnings per share came in at a loss of US$0.56. Against that, revenue of US$294.4m and a...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Is Ambarella (AMBA) Still Undervalued Or Close To Fair Value?

Ambarella stock has declined 27.2% over the past 5 years, yet its current valuation checks present a mixed picture, with a Discounted Cash Flow (DCF) intrinsic value estimate indicating potential upside, while market based multiples appear closer to fair. The share price performance over 5 years, down 27.2%, suggests investors have not been fully rewarded for holding Ambarella over this period. Expectations for Ambarella's ability to convert its product pipeline into consistent cash flows...
NasdaqGS:CECO
NasdaqGS:CECOMachinery

Is CECO Environmental’s (CECO) Oversold Signal Masking a Quiet Upgrade in Its Earnings Narrative?

In late July 2026, CECO Environmental was flagged as technically oversold even as analysts raised earnings estimates and assigned it a top-tier Zacks Rank, pointing to expectations for an earnings surprise around the company’s August 6 report. This combination of oversold technicals and increasingly optimistic earnings revisions has sharpened investor focus on whether CECO’s fundamental outlook is improving faster than sentiment suggests. We’ll now examine how the anticipated earnings beat...